SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Repros Therapeutics, Inc. – RPRX
[PR Newswire] – NEW YORK, May 5, 2014 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Repros Therapeutics, Inc. (Repros or the Company) (RPRX) (CUSIP:76028H209). Investors are advised to contact Robert S. Willoughby at rsw more
View todays social media effects on RPRX
View the latest stocks trending across Twitter. Click to view dashboard